Recent advances in managing gastrointestinal stromal tumor [version 1; referees: 2 approved]
Constitutive activating mutations in KIT and platelet-derived growth factor receptor α (PDGFRα) are heavily involved in the pathobiology of gastrointestinal stromal tumors (GISTs). This disease has served as an effective “proof-of-concept” model for targeting gain-of-function kinase mutations in can...
Main Authors: | Florence Duffaud, Axel Le Cesne |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-09-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-1689/v1 |
Similar Items
-
Recent advances in preoperative management of esophageal adenocarcinoma [version 1; referees: 2 approved]
by: Kazuto Harada, et al.
Published: (2017-04-01) -
Hyperthermic intraperitoneal chemoperfusion with high dose oxaliplatin: Influence of perfusion temperature on postoperative outcome and survival [version 2; referees: 1 approved, 2 approved with reservations]
by: Johanna Verhulst
Published: (2015-10-01) -
Advances in upper gastrointestinal endoscopy [version 1; referees: 2 approved]
by: David G. Graham, et al.
Published: (2015-12-01) -
Recent advances in the management of Wilms' tumor [version 1; referees: 2 approved]
by: Roberto I. Lopes, et al.
Published: (2017-05-01) -
Recent Advances in Endometrial Cancer [version 1; referees: 2 approved]
by: Arthur-Quan Tran, et al.
Published: (2017-01-01)